These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2243 related items for PubMed ID: 15457467

  • 21. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C, Hartford J, Russell J, Ball S, Erickson J, Raskin J, Rynn M.
    Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.
    Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
    [Abstract] [Full Text] [Related]

  • 23. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

  • 24. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
    Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF.
    Pain; 2005 Dec 15; 119(1-3):5-15. PubMed ID: 16298061
    [Abstract] [Full Text] [Related]

  • 25. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S.
    Rheumatol Int; 2002 Sep 15; 22(5):188-93. PubMed ID: 12215864
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 15; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 27. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
    Perahia DG, Kajdasz DK, Walker DJ, Raskin J, Tylee A.
    Int J Clin Pract; 2006 May 15; 60(5):613-20. PubMed ID: 16700869
    [Abstract] [Full Text] [Related]

  • 28. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group.
    Arthritis Rheum; 2009 Jan 15; 60(1):299-309. PubMed ID: 19116896
    [Abstract] [Full Text] [Related]

  • 29. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.
    Ann Clin Psychiatry; 2008 Jan 15; 20(4):187-93. PubMed ID: 19034749
    [Abstract] [Full Text] [Related]

  • 30. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS.
    Semin Arthritis Rheum; 2010 Jun 15; 39(6):454-64. PubMed ID: 19152958
    [Abstract] [Full Text] [Related]

  • 31. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK, Mallinckrodt CH, Detke MJ, Watkin JG, Tollefson GD.
    J Psychiatr Res; 2005 Mar 15; 39(2):161-72. PubMed ID: 15589564
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B.
    Arthritis Rheum; 2012 Jul 15; 64(7):2387-97. PubMed ID: 22275142
    [Abstract] [Full Text] [Related]

  • 33. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
    Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H.
    Clin J Pain; 2009 Jun 15; 25(5):365-75. PubMed ID: 19454869
    [Abstract] [Full Text] [Related]

  • 34. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM, Pritchett YL, D'Souza DN, Kajdasz DK, Iyengar S, Wernicke JF.
    J Womens Health (Larchmt); 2007 Oct 15; 16(8):1145-56. PubMed ID: 17937567
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 15; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 36. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
    Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI.
    Arthritis Rheum; 2007 Apr 15; 56(4):1336-44. PubMed ID: 17393438
    [Abstract] [Full Text] [Related]

  • 37. Electroconvulsive therapy in patients with depression and fibromyalgia.
    Huuhka MJ, Haanpää ML, Leinonen EV.
    Eur J Pain; 2004 Aug 15; 8(4):371-6. PubMed ID: 15207518
    [Abstract] [Full Text] [Related]

  • 38. Pain response profile of patients with fibromyalgia treated with duloxetine.
    Bradley LA, Wohlreich MM, Wang F, Gaynor PJ, Robinson MJ, D'Souza DN, Mease PJ.
    Clin J Pain; 2010 Aug 15; 26(6):498-504. PubMed ID: 20551724
    [Abstract] [Full Text] [Related]

  • 39. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.
    J Psychiatr Res; 2005 Jan 15; 39(1):43-53. PubMed ID: 15504423
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial.
    Brecht S, Desaiah D, Marechal ES, Santini AM, Podhorna J, Guelfi JD.
    J Clin Psychiatry; 2011 Aug 15; 72(8):1086-94. PubMed ID: 20868642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 113.